| Date Filed | Type | Description |
| 08/07/2023 |
4
| Jordan Julie (Chief Medical Officer) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 436 shares
@ $1.39, valued at
$606
Sold 109 shares
@ $1.39, valued at
$151.5
Sold 1,308 shares
@ $1.39, valued at
$1.8k
Exercised 1,548 restricted stock units
@ $0
Exercised 387 restricted stock units
@ $0
Exercised 4,644 restricted stock units
@ $0 |
|
| 08/04/2023 |
4
| Jordan Julie (Chief Medical Officer) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 99 shares
@ $1.31, valued at
$129.7
Exercised 350 restricted stock units
@ $0 |
|
| 06/15/2023 |
4
| GILLIS STEVEN (Director) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 23,000 options to buy
@ $1.03, valued at
$23.7k
|
|
| 06/15/2023 |
4
| Patterson Matthew R (Director) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 23,000 options to buy
@ $1.03, valued at
$23.7k
|
|
| 06/15/2023 |
4
| Thistle Mary (Director) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 23,000 options to buy
@ $1.03, valued at
$23.7k
|
|
| 06/15/2023 |
4
| TZIANABOS ARTHUR (Director) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 23,000 options to buy
@ $1.03, valued at
$23.7k
|
|
| 06/15/2023 |
4
| Poulton Jeffrey V. (Director) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 23,000 options to buy
@ $1.03, valued at
$23.7k
|
|
| 06/15/2023 |
4
| REICIN ALISE (Director) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 23,000 options to buy
@ $1.03, valued at
$23.7k
|
|
| 03/16/2023 |
3
| Jordan Julie (Chief Medical Officer) has filed a Form 3 on Homology Medicines, Inc. |
| 03/06/2023 |
4
| Alloway Paul (See Remarks) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 10,965 shares
@ $1.4467, valued at
$15.9k
|
|
| 02/27/2023 |
4
| Alloway Paul (See Remarks) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 164,000 options to buy
@ $1.6, valued at
$262.4k
Granted 27,000 restricted stock units
@ $0 |
|
| 02/27/2023 |
4
| Blum Michael Lee (Chief Commercial Officer) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 104,000 options to buy
@ $1.6, valued at
$166.4k
Granted 17,000 restricted stock units
@ $0 |
|
| 02/27/2023 |
4
| Smith W Bradford (See remarks) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 213,000 options to buy
@ $1.6, valued at
$340.8k
Granted 36,000 restricted stock units
@ $0 |
|
| 02/27/2023 |
4
| Seymour Albert (See Remarks) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 632,000 options to buy
@ $1.6, valued at
$1M
Granted 105,000 restricted stock units
@ $0 |
|
| 01/20/2023 |
3/A
| Blum Michael Lee (Chief Commercial Officer) has filed a Form 3/A on Homology Medicines, Inc. |
| 01/20/2023 |
4/A
| Blum Michael Lee (Chief Commercial Officer) has filed a Form 4 on Homology Medicines, Inc. |
| 01/20/2023 |
4/A
| Alloway Paul (See Remarks) has filed a Form 4 on Homology Medicines, Inc. |
| 01/20/2023 |
4/A
| Seymour Albert (See Remarks) has filed a Form 4 on Homology Medicines, Inc. |
| 01/11/2023 |
4
| Blum Michael Lee (Chief Commercial Officer) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 2,454 shares
@ $1.3904, valued at
$3.4k
|
|
| 01/11/2023 |
4
| Alloway Paul (See Remarks) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 3,090 shares
@ $1.3903, valued at
$4.3k
|
|
| 01/11/2023 |
4
| Smith W Bradford (See Remarks) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 3,729 shares
@ $1.3912, valued at
$5.2k
|
|
| 01/11/2023 |
4
| Seymour Albert (See Remarks) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 3,620 shares
@ $1.3904, valued at
$5k
|
|
| 01/11/2023 |
4
| TZIANABOS ARTHUR (Director) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 10,616 shares
@ $1.3905, valued at
$14.8k
|
|
| 01/04/2023 |
4
| Blum Michael Lee (Chief Commercial Officer) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Exercised 2,640 restricted stock units
@ $0
Exercised 4,950 restricted stock units
@ $0 |
|
| 01/04/2023 |
4
| TZIANABOS ARTHUR (Director) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Exercised 13,860 restricted stock units
@ $0
Exercised 19,140 restricted stock units
@ $0 |
|
| 01/04/2023 |
4
| Seymour Albert (See Remarks) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Exercised 4,290 restricted stock units
@ $0
Exercised 6,930 restricted stock units
@ $0 |
|
| 01/04/2023 |
4
| Smith W Bradford (See Remarks) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Exercised 6,600 restricted stock units
@ $0
Exercised 6,930 restricted stock units
@ $0 |
|
| 01/04/2023 |
4
| Alloway Paul (See Remarks) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Exercised 4,290 restricted stock units
@ $0
Exercised 5,280 restricted stock units
@ $0 |
|
| 09/08/2022 |
4
| Seymour Albert (See remarks) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 23,000 options to buy
@ $2.18, valued at
$50.1k
Granted 14,000 restricted stock units
@ $0 |
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| REICIN ALISE (Director) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 18,000 options to buy
@ $1.88, valued at
$33.8k
|
|
|